🔎 Trials Near Me

Home › Kanser (lahat ng uri) › Maine

Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Maine

6 pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa mga site sa Maine.

Mga Lungsod sa Maine

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05256225

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Harold Alfond Center for Cancer Care, Augusta
  • Jackson Laboratory - Maine Cancer Genomics Initiative, Augusta
  • Waldo County General Hospital, Belfast
  • at 16 pa
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

Project: Every Child for Younger Patients With Cancer

  • Eastern Maine Medical Center, Bangor
  • Maine Children's Cancer Program, Scarborough
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • Maine Health, Portland
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05335928

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scarborough
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.